Angiogenesis, Exudation, and Degeneration 2024

Add to Calendar Angiogenesis, Exudation, and Degeneration 2024 2/3/2024 7:50:00 AM 2/3/2024 8:45:00 PM America/New_York For More Details: https://miami.cloud-cme.com/course/courseoverview?EID=13569 Description: Angiogenesis 2024 follows the tradition of excellence established by Bascom Palmer’s widely acclaimed Angiogenesis programs between 2004 and 2023. Designed for retina specialists, general ophthalmologists and researchers, the current program will review the latest in imaging, translational research, and clinical trials with an emphasis on how these results will impact clinical ophthalmology. We will em... Online false MM/DD/YYYY


Date & Location
Saturday, February 3, 2024, 7:50 AM - 8:45 PM, Online

Target Audience
Specialties - Ophthalmology

Credits
AMA PRA Category 1 Credits™ (12.75 hours), Non-Physician Attendance (12.75 hours)

Overview
Angiogenesis 2024 follows the tradition of excellence established by Bascom Palmer’s widely acclaimed Angiogenesis programs between 2004 and 2023. Designed for retina specialists, general ophthalmologists and researchers, the current program will review the latest in imaging, translational research, and clinical trials with an emphasis on how these results will impact clinical ophthalmology. We will emphasize early phase clinical trials and recently completed studies focused on the treatment of a wide range of retinal diseases with special emphasis on age-related macular degeneration, diabetic retinopathy, and retinal vascular diseases

Objectives
At the conclusion of this activity, learners will be able to:

  1. Examine new evidence for understanding the pathophysiology in nonexudative age-related macular degeneration
  2. Examine new evidence for predicting disease progression in nonexudative age-related macular degeneration
  3. Evaluate the benefits and limitations of different imaging technologies in the diagnosis and clinical management of macular and retinal diseases
  4. Incorporate the latest advances in artificial intelligence, specifically machine learning, for the diagnosis and treatment of retinal diseases
  5. Evaluate emerging therapies for the treatment of nonexudative age-related macular degeneration and review the real-world outcomes following the use of complement inhibitors in clinical practice to better understand the population most likely to benefit from these drugs are approved
  6. Evaluate therapies targeting novel disease pathways being investigated in early-stage clinical trials for nonexudative age-related macular degeneration
  7. Provide an update on the next generation of anti-VEGF therapies recently approved and currently in development
  8. Evaluate the clinical use of available anti-VEGF drugs for exudative ocular diseases

Registration
To register please visit: Angiogenesis, Exudation, and Degeneration 2024 – Virtual Edition website
Accreditation
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

The University of Miami Leonard M. Miller School of Medicine designates this Live Activity for a maximum of 12.75 of AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME


Additional Information

Accessibility Statement
 
University of Miami Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.



Keywords: LIVE